Physician profile
Mark B Lew
NPI 1851357560
$1,327.62
in general payments reported to CMS, 2019-2025
10 companies · $236 in 2025
The $236 reported for 2025 was more than what 78% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $17.96 · 2021: $71.11 · 2022: $71.41 · 2023: $286 · 2024: $156 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $720.39 | 2019-2025 | Bexsero, Penmenvy |
| Pfizer INC. | $338.25 | 2019-2024 | |
| Phadia US INC. | $98.95 | 2019-2025 | Immunocap |
| Cranial Technologies, INC | $33.91 | 2022-2025 | Doc Band |
| Astrazeneca Pharmaceuticals LP | $28.32 | 2023 | Flumist Quadrivalent |
| Merck Sharp & Dohme LLC | $27.73 | 2024 | Gardasil 9, Gardasil, Rotateq |
| Seqirus USA INC | $23.08 | 2024 | Flucelvax |
| Cumberland Pharmaceuticals, INC. | $20.84 | 2024 | Kristalose |
| Alk-Abello, INC | $18.84 | 2025 | Neffy |
| Sobi, INC | $17.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.